NIVF

NewGenIvf Group Limited Class A Ordinary Shares
NASDAQHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$3.60M
P/E Ratio
0.01
EPS
$109.44
Beta
-0.00
52W High
$513.00
52W Low
$0.45
50-Day MA
$1.33
200-Day MA
$20.33
Dividend Yield
Profit Margin
209.00%
Forward P/E
0.04
PEG Ratio

About NewGenIvf Group Limited Class A Ordinary Shares

NewGenIvf Group Limited (NIVF) is a pioneering organization in the reproductive health industry, specializing in innovative fertility solutions, including advanced in vitro fertilization (IVF) services. The company is dedicated to enhancing success rates in assisted reproductive technologies and is strategically positioned to capitalize on the growing global demand for fertility treatments, supported by a robust network of clinics and strategic partnerships. As the fertility services market continues to expand, NIVF is well-equipped for substantial growth, with a mission to assist individuals and couples in their journey to parenthood through forward-thinking healthcare solutions.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$4.73M
Gross Profit (TTM)955,850
EBITDA$-10.54M
Operating Margin-349.10%
Return on Equity79.40%
Return on Assets-36.90%
Revenue/Share (TTM)$308.19
Book Value$331.51
Price-to-Book0.13
Price-to-Sales (TTM)0.76
EV/Revenue1.592
EV/EBITDA0.69
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)11.90%
Shares Outstanding$5.92M
Float188,310
% Insiders0.00%
% Institutions1.47%

Historical Volatility

HV 10-Day
123.03%
HV 20-Day
121.57%
HV 30-Day
109.67%
HV 60-Day
HV Rank

Volatility is currently expanding

Analyst Ratings

Consensus ($42.36 target)

Latest News

NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor

BANGKOK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has completed an exchange agreement with a certain institutional investor (“Investor”) pursuant to which existing convertible notes held by the Investor were exchanged for a new senior convertible note on amended terms. The exchange closed on August 14, 2026.

GlobeNewsWire8/17/2026Neutral
NewGen Provides Update on K25.ai Investment and Strengthened Financial Position

NewGen's total shares outstanding count expected to reach 5.9 million following recently announced share issuance, bolstering market capitalization NewGen's agreed 13% stake in K25.ai is now valued at approximately US$26 million, based on K25.ai's recently closed Series A investment round, representing an unrealized gain of about US$8.5 million BANGKOK, July 30, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today provided an update on its strategic investment in K25.ai and the related impact on the Company's capitalization and financial position. NewGen reported net profit attributable to shareholders of US$9.9 million for the fiscal year ended December 31, 2025, with net assets of approximately US$25.98 million as of that date.

GlobeNewsWire7/30/2026Neutral
NewGen's Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai's Valuation Reaches US$200 Million

K25.ai closes Series A investment round, reaching a post-money valuation of US$200 million NewGen's 10% ownership stake in K25.ai has reached US$20 million in value and generated a ~US$10 million unrealized gain, expected to be booked in 2026 BANGKOK, July 23, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today highlighted that K25.ai has closed its Series A investment round with strategic support from the Singapore-based digital assets firm Amber Group. The latest round values K25.ai at a post-money valuation of US$200 million, doubling its US$100 million Pre-A valuation in under 60 days.

GlobeNewsWire7/23/2026Neutral
NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy

NewGen's 6% Stake in K25.ai Now Valued at US$6 Million Company will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced it has exercised its top-up option to acquire an additional 4% equity interest in AI-native livestreaming prediction market platform K25.ai, raising its total holding to 6%. The additional US$4 million investment, which supplements an initial US$2 million investment announced in May 2026, is split evenly between cash and newly issued NewGen Class A ordinary shares.

GlobeNewsWire6/4/2026Neutral
NewGen Executes Share Purchase Agreement and Obtains Exclusive APAC Agency Rights with K25.ai, an AI-Powered Prediction Market Led by Industry Veteran Andy Cheung

NewGen executes Share Purchase Agreement to acquire an initial 2% equity interest in K25.ai, with the right to invest up to 10% in total NewGen also executes Exclusive Agency Agreement with K25.ai, appointing NewGen as K25.ai's exclusive agency partner for selected permitted APAC markets, creating a potential asset-light commercial growth channel According to media reports citing Bernstein research, prediction market volumes could reach approximately US$1 trillion by 2030 as the category evolves into broader information markets across sports, crypto, politics, macroeconomic and event-driven contracts APAC market tailwinds across mobile, digital economy, gaming, esports, live-streaming, social video and AI-enabled engagement provide a compelling foundation for localized prediction and information-market platforms BANGKOK, May 28, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has executed a Share Purchase Agreement and an Exclusive Agency Agreement with K25.ai, an APAC-focused AI-powered live-streaming and watch-to-predict platform led by technology veteran Andy Cheung. Under the Share Purchase Agreement, NewGen will acquire an initial 2% equity interest in K25.ai for US$2 million, implying a US$100 million valuation, with the right to increase its ownership to up to 10% on the same valuation terms.

GlobeNewsWire5/28/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NIVF and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 8/18/2026